Manchester Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.5K	Buy	86 +2	+2%	+$681	﹤0.01%	605
2025 Q4	$33.4K	Buy	84 +72	+600%	+$31.9K	﹤0.01%	564
2025 Q3	$5.47K	Buy	12 +9	+300%	+$3.67K	﹤0.01%	941
2025 Q2	$979	Buy	3 +1	+50%	+$277	﹤0.01%	1063
2025 Q1	$541	Hold	2	–	–	﹤0.01%	1081
2024 Q4	$471	Hold	2	–	–	﹤0.01%	1084
2024 Q3	$551	Hold	2	–	–	﹤0.01%	1077
2024 Q2	$486	Sell	2 -1	-33%	-$158	﹤0.01%	1062
2024 Q1	$449	Hold	3	–	–	﹤0.01%	949
2023 Q4	$575	Hold	3	–	–	﹤0.01%	901
2023 Q3	$532	Hold	3	–	–	﹤0.01%	897
2023 Q2	$570	Buy	+3	New	+$595	﹤0.01%	869
2020 Q4	–	Sell	-3	Closed	–	–	729
2020 Q3	$0	Buy	+3	New	+$426	﹤0.01%	549